ATF6-Mediated Signaling Contributes to PARP Inhibitor Resistance in Ovarian Cancer.
McMellen A, Yamamoto TM, Qamar L, Sanders BE, Nguyen LL, Ortiz Chavez D, Bapat J, Berning A, Post MD, Johnson J, Behbakht K, Nurmemmedov E, Chuong EB, Bitler BG.
McMellen A, et al.
Mol Cancer Res. 2023 Jan 3;21(1):3-13. doi: 10.1158/1541-7786.MCR-22-0102.
Mol Cancer Res. 2023.
PMID: 36149636
Free PMC article.